Using blood tests to improve prognosis and treatment for osteosarcoma
Liquid biopsy approaches to inform osteosarcoma prognosis and tumor evolution
This study is looking at how a new blood test can help us understand and improve treatment for kids and young adults with osteosarcoma, a type of bone cancer, by tracking changes in tumor DNA in their blood.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10883604 on NIH RePORTER |
What this research studies
This research focuses on osteosarcoma, a type of bone cancer that primarily affects children and young adults. It aims to utilize innovative liquid biopsy techniques to analyze circulating tumor DNA (ctDNA) in the blood, which may provide insights into tumor evolution and prognosis. By identifying reliable biomarkers, the study seeks to enhance treatment strategies and outcomes for patients with this aggressive cancer. The approach involves monitoring ctDNA levels to correlate with disease progression and response to therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and young adults diagnosed with osteosarcoma.
Not a fit: Patients with other types of cancer or those who are not diagnosed with osteosarcoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options and improved prognostic tools for patients with osteosarcoma.
How similar studies have performed: Other research has shown promise in using liquid biopsy techniques for various cancers, indicating potential success for this novel approach in osteosarcoma.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Crompton, Brian — Dana-Farber Cancer Inst
- Study coordinator: Crompton, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.